NATIXIS - Meeting notice combined general shareholder's meeting

CONSOLIDATED FINANCIAL STATEMENTS AND NOTES

CONSOLIDATED BALANCE SHEET¢– ASSETS

Notes

31/12/2018

01/01/2018 31/12/2017¢(a)

(inmillions of euros)

Cash, central banks

24,291

36,901

36,901

Financial assets at fair value through profit or loss

8.1

214,086

225,663

184,497

Hedging derivatives

8.2

306

337

339

Financial assets at fair value through other comprehensive income

8.4

10,798

9,981

Available-for-sale financial assets

57,885

Debt instruments at amortized cost

8.6.3

1,193

984

Loans and receivables due from banks and similar items at amortized cost Loans and receivables due from customers at amortized cost

8.6.1

27,285

40,570

45,289

8.6.2

69,279

84,512

136,768

› o/w institutional operations

839

779

779

Revaluation adjustments on portfolios hedged against interest rate risk Insurance business investments

9.4

100,536

96,901

Held-to-maturity financial assets

1,885

Current tax assets

258

577

577

Deferred tax assets

1,456

1,622

1,585

Accrual accounts and other assets

8.1

14,733

15,267

46,624

Non-current assets held for sale (b)

8.9

25,646

738

738

Deferred profit-sharing Investments in associates

735

732

734

Investment property

0

124

1,073

Property, plant and equipment

8.11

420

758

758

Intangible assets

8.11

678

732

732

Goodwill

8.13

3,796

3,601

3,601

TOTAL ASSETS 519,987 (a) The information reported at Decemberb31, 2017 has not been restated for the impact of the first-time application of IFRSb9 “Financial Instruments”, in accordance with the provisions 495,496 520,000

of this standard. The impact of the first-time application of IFRSb9 on the opening balance sheet at Januaryb1, 2018 is presented in detail in Noteb1. (b) Corresponds to the SFS business lines recognized in non-current assets held for sale as at Decemberb31, 2018 (also see Notesb3.6 and 6.9).

12

NATIXIS 2019 MEETING NOTICE